MedPath

Xyveemox

Brand Name: Xyveemox

Generic Name: Co-Amoxiclav

Active
Registration Number

DRP-2645-02

Dosage Form

Film-Coated Tablet

Issuance Date

August 24, 2021

Expiry Date

June 18, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength625 mg
PackagingAlu-Alu Foil Strip x 6 (Box of 12's) and Alu-Alu Foil Strip x 7 (Box of 14's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antibacterial (Penicillin/Beta-Lactamase Inhibitor combination)
A
Application
CLIDP Conversion
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Co-AmoxiclavActive
Monograph: co-amoxiclav

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform